palmidrol has been researched along with Acute Confusional Senile Dementia in 9 studies
palmidrol: a cannabinoid receptor-inactive eCB-related molecule used as prophylactic in helping to prevent respiratory viral infection
palmitoyl ethanolamide : An N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an aging society, Alzheimer's disease (AD) exerts an increasingly serious health and economic burden." | 1.48 | Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects. ( Bellanti, F; Broad, KD; Bronzuoli, MR; Canese, R; Carpinelli, G; Cassano, T; Facchinetti, R; Ferraro, L; Gaetani, S; Pace, L; Palombelli, G; Scuderi, C; Serviddio, G; Steardo, L, 2018) |
| "The exposure to Aβ₄₂ induced toxic effects on cultured cortical neurons and astrocytes from non-Tg mice, but not in those from 3xTg-AD mice." | 1.42 | Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice. ( Antonelli, T; Beggiato, S; Borelli, AC; Cassano, T; Ferraro, L; Tanganelli, S; Tomasini, MC, 2015) |
| "PEA failed to rescue memory deficits induced by Ab25-35 injection in peroxisome proliferator-activated receptor-α (PPAR-α) null mice." | 1.38 | Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease. ( Avagliano, C; Calignano, A; Cristiano, C; D'Agostino, G; Meli, R; Russo, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Assogna, M | 1 |
| Di Lorenzo, F | 1 |
| Martorana, A | 1 |
| Koch, G | 1 |
| Beggiato, S | 2 |
| Cassano, T | 4 |
| Ferraro, L | 3 |
| Tomasini, MC | 2 |
| Petrosino, S | 1 |
| Schiano Moriello, A | 1 |
| Scuderi, C | 4 |
| Bronzuoli, MR | 3 |
| Facchinetti, R | 2 |
| Pace, L | 1 |
| Broad, KD | 1 |
| Serviddio, G | 1 |
| Bellanti, F | 1 |
| Palombelli, G | 1 |
| Carpinelli, G | 1 |
| Canese, R | 1 |
| Gaetani, S | 1 |
| Steardo, L | 7 |
| Romano, A | 1 |
| Stecca, C | 2 |
| Passarella, S | 1 |
| Valenza, M | 1 |
| Ratano, P | 1 |
| Bartoli, S | 1 |
| Pompili, E | 1 |
| Fumagalli, L | 1 |
| Campolongo, P | 1 |
| Borelli, AC | 1 |
| Tanganelli, S | 1 |
| Antonelli, T | 1 |
| D'Agostino, G | 1 |
| Russo, R | 1 |
| Avagliano, C | 1 |
| Cristiano, C | 1 |
| Meli, R | 1 |
| Calignano, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Palmitoylethanolamide on Reducing Opioid Consumption for Postoperative Pain and Inflammation Following Below Knee Fracture Fixation: A Pilot Study.[NCT05317676] | Phase 2 | 0 participants (Actual) | Interventional | 2023-05-31 | Withdrawn (stopped due to Sponsor suspending temporarily.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for palmidrol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders.
Topics: Alzheimer Disease; Amides; Animals; Ethanolamines; Neurodegenerative Diseases; Palmitic Acids | 2022 |
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
Topics: Alzheimer Disease; Amides; Amyotrophic Lateral Sclerosis; Animals; Autism Spectrum Disorder; Endocan | 2020 |
7 other studies available for palmidrol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Astrocytes; Cell Survival; Cerebral Corte | 2020 |
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.
Topics: Age Factors; Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Be | 2018 |
Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease:
Topics: Alzheimer Disease; Amides; Animals; Astrocytes; Disease Models, Animal; Ethanolamines; Gliosis; Huma | 2018 |
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Animals; Disease Models, Animal; Ethanolamines; Gliosis; Humans; Male; Ne | 2014 |
Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Disease Models, Animal; Endocannabinoids; | 2012 |
Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Animals; Cell Survival; Cells, Cultured; Disease Models, Animal; Endocann | 2013 |